Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Amortization - Intangibles came in at $241.0 million in Q1 2026, down 5.86% year-on-year from $256.0 million in Q1 2025, and up 2.12% quarter-over-quarter from $236.0 million in Q4 2025.
Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Amortization - Intangibles across 18 years of filings, most recently posting $241.0 million for Q1 2026.
- Amortization - Intangibles for Q1 2026 came in at $241.0 million, down 5.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $986.0 million (down 6.89% YoY), and the FY2025 annual result was $1.0 billion, down 7.06% from the prior year.
- Amortization - Intangibles came in at $241.0 million for Q1 2026 at Bausch Health Companies, up from $236.0 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $313.0 million in Q4 2022 to a low of $236.0 million in Q4 2025.
- The 5-year median for Amortization - Intangibles is $270.0 million (2024), against an average of $271.2 million.
- Across the five-year window, Amortization - Intangibles decreased 16.11% in 2022 and rose 8.3% in 2024, its largest moves.
- Bausch Health Companies' Amortization - Intangibles stood at $313.0 million in 2022, then slipped by 9.9% to $282.0 million in 2023, then slipped by 8.16% to $259.0 million in 2024, then slipped by 8.88% to $236.0 million in 2025, then rose by 2.12% to $241.0 million in 2026.
- The last three Amortization - Intangibles figures came in at $241.0 million (Q1 2026), $236.0 million (Q4 2025), and $253.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 241.00 Mn |
| Dec 31, 2025 | 236.00 Mn |
| Sep 30, 2025 | 253.00 Mn |
| Jun 30, 2025 | 256.00 Mn |
| Mar 31, 2025 | 256.00 Mn |
| Dec 31, 2024 | 259.00 Mn |
| Sep 30, 2024 | 274.00 Mn |
| Jun 30, 2024 | 270.00 Mn |
| Mar 31, 2024 | 274.00 Mn |
| Dec 31, 2023 | 282.00 Mn |
| Sep 30, 2023 | 253.00 Mn |
| Jun 30, 2023 | 269.00 Mn |
| Mar 31, 2023 | 273.00 Mn |
| Dec 31, 2022 | 313.00 Mn |
| Sep 30, 2022 | 290.00 Mn |
| Jun 30, 2022 | 302.00 Mn |
| Mar 31, 2022 | 310.00 Mn |
| Dec 31, 2021 | 320.00 Mn |
| Sep 30, 2021 | 338.00 Mn |
| Jun 30, 2021 | 360.00 Mn |